North America E. coli Testing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging); End User (Commercial or Private Labs, Physician Offices, Hospitals, Public Health Labs, and Academic Research Institutes), and Country

No. of Pages: 125    |    Report Code: TIPRE00012213    |    Category: Consumer Goods

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America E. coli Testing Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America E. coli Testing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America E. coli Testing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing E. coli Testing
5.2 Market Opportunities
  • 5.2.1 Developments in biotechnology
5.3 Future Trends
  • 5.3.1 Growth Opportunities in Developing Regions
5.4 Impact of Drivers and Restraints

6. North America E. coli Testing Market Regional Analysis

6.1 North America E. coli Testing Market Overview
6.2 North America E. coli Testing Market Revenue 2017-2027 (US$ Million)
6.3 North America E. coli Testing Market Forecast Analysis

7. North America E. coli Testing Market Analysis – by Technology

7.1 Monoclonal Antibodies
  • 7.1.1 Overview
  • 7.1.2 Monoclonal Antibodies: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Differential Light Scattering
  • 7.2.1 Overview
  • 7.2.2 Differential Light Scattering: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Molecular Diagnostics
  • 7.3.1 Overview
  • 7.3.2 Molecular Diagnostics: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Immunoassays
  • 7.4.1 Overview
  • 7.4.2 Immunoassays: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Chromatography
  • 7.5.1 Overview
  • 7.5.2 Chromatography: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Flow Cytometry
  • 7.6.1 Overview
  • 7.6.2 Flow Cytometry: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Gel Microdroplets
  • 7.7.1 Overview
  • 7.7.2 Gel Microdroplets: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Diagnostic Imaging
  • 7.8.1 Overview
  • 7.8.2 Diagnostic Imaging: North America E. coli Testing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America E. coli Testing Market Analysis – by End User

8.1 Commercial or Private Labs
  • 8.1.1 Overview
  • 8.1.2 Commercial or Private Labs: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Physician Offices
  • 8.2.1 Overview
  • 8.2.2 Physician Offices: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Hospitals
  • 8.3.1 Overview
  • 8.3.2 Hospitals: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Public Health Labs
  • 8.4.1 Overview
  • 8.4.2 Public Health Labs: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Academic Research Institutes
  • 8.5.1 Overview
  • 8.5.2 Academic Research Institutes: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)

9. North America E. coli Testing Market – North America Analysis

9.1 North America
  • 9.1.1 North America E. coli Testing Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 9.1.1.1 North America E. coli Testing Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 US: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.1.1 US: North America E. coli Testing Market Breakdown, by Technology
    • 9.1.1.1.2 US: North America E. coli Testing Market Breakdown, by End User
  • 9.1.1.2 Canada: North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.2.1 Canada: North America E. coli Testing Market Breakdown, by Technology
    • 9.1.1.2.2 Canada: North America E. coli Testing Market Breakdown, by End User
  • 9.1.1.3 Mexico : North America E. coli Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.3.1 Mexico : North America E. coli Testing Market Breakdown, by Technology
    • 9.1.1.3.2 Mexico : North America E. coli Testing Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. North America E. coli Testing Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Bio-Rad Laboratories, Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Pro-Lab Diagnostics, Inc.
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Abbott (Alere Inc.)
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 IDEXX Laboratories, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Meridian Bioscience, Inc.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 BD
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Thermo Fisher Scientific, Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 NEOGEN Corporation
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Hologic, Inc.
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - North America E. coli Testing Market

The List of Companies - North America E. coli Testing Market

  1. Bio-Rad Laboratories, Inc
  2. Pro-Lab Diagnostics, Inc.
  3. Abbott (Alere Inc.)
  4. IDEXX Laboratories, Inc.
  5. Meridian Bioscience, Inc.
  6. BD
  7. Thermo Fisher Scientific, Inc.
  8. NEOGEN Corporation
  9. Hologic, Inc.